METAMeta Platforms, Inc.
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $7.40Beat
- vs $6.52 expected on Oct 21
- Stock move on it
- −6.98%
- one session
- Typical move
- ±7.5%
- average over 2 reports
- Price
- $623.59
- −0.82% today · $1.49T cap
Past and upcoming reports
2
| Oct 21, 2026 | Sep 30, 2026 | Time not given | $6.52 | Beat$7.40 | −6.98% |
| Jul 29, 2026 | Jun 30, 2026 | Time not given | $7.48 | Missed$6.18 | −7.95% |
After the report
Jul 29, 2026 report
This covers the Jul 29, 2026 report. The Oct 21, 2026 numbers are in the table above.
META Q2 Miss: EPS -14.4% as FCF Collapse Sparks Selloff, Oversold Bounce Underway
Meta reported Q2 EPS of $6.18 vs $7.22 consensus (-14.4% miss). Revenue grew 28% but free cash flow collapsed 91% to $784M from $9B due to massive AI capex. The stock initially dropped ~8% on the news but has since bounced 3.2% today as oversold conditions and cheap valuation (forward P/E 15.7x) attract buyers. Analyst consensus remains Buy with $761 target (+49% upside), but near-term margin pressure and capex uncertainty cloud the outlook.
Reported against expected
MissedEPS miss of -14.42%: reported $6.18 vs estimated $7.22.
Guidance
No specific forward guidance provided. focus shifted to AI capex and FCF sustainability.
How the stock reacted
Stock fell ~8% on earnings day (July 29) after the miss and FCF collapse, but recovered 3.2% today (July 31) on oversold buying. RSI 14 at 22.8.
What changed
EPS missed by 14.4% and FCF collapsed 91% to $784M on elevated AI capex.
What the price now assumes
Market priced in margin and FCF risk. oversold (RSI 22.8) and cheap valuation (forward P/E 15.7) limit downside.
What it means for the business
Upgrade bias on valuation. watch Q3 revenue deceleration or FCF stabilization for confirmation.
The next one to three months, as we saw it then
Better case30%
AI monetization accelerates, revenue growth stays >20%, capex peaks, and FCF recovers toward $3-4B per quarter, driving multiple re-rating.
Base case50%
Revenue grows 18-22% but capex stays elevated, keeping FCF subdued around $1-2B. Stock trades range-bound between $500-600 as market digests the investment cycle.
Worse case20%
Capex continues to outpace revenue, FCF stays depressed, revenue decelerates to <15%, and margins compress further, leading to a drift toward $450-500.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.